The monocytic component in myelodysplastic syndromes.
Castoldi
G
G
Hematology Section, University of Ferrara, Italy.
Rigolin
G M
GM
D000818:Animals; D001854:Bone Marrow Cells / Q000473:pathology; D002454:Cell Differentiation; D002881:Chromosomes, Human, Pair 12 / Q000648:ultrastructure; D002895:Chromosomes, Human, Pair 5 / Q000648:ultrastructure; D002898:Chromosomes, Human, Pair 8; D003713:Dendritic Cells / Q000473:pathology; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006801:Humans; D016130:Immunophenotyping; D015477:Leukemia, Myelomonocytic, Chronic / Q000145:classification / Q000235:genetics / Q000401:mortality / Q000473:pathology; D015993:Life Tables; D008264:Macrophages / Q000473:pathology; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D009000:Monocytes / Q000473:pathology*; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D022423:Myeloid Cells / Q000473:pathology; D009196:Myeloproliferative Disorders / Q000145:classification; D014411:Neoplastic Stem Cells / Q000473:pathology; D009857:Oncogenes; D011379:Prognosis; D016019:Survival Analysis; D014178:Translocation, Genetic; D014183:Transplantation, Heterologous; D014314:Trisomy